Literature DB >> 32492811

Evaluating Residential Segregation's Relation to the Clustering of Poor Health across American Cities.

Joseph Gibbons1, Tse-Chuan Yang2, Elizabeth Brault3, Michael Barton3.   

Abstract

Residential segregation by race/ethnicity is widely recognized as a leading source of health disparities. Not clear from past research, however, is the overall health burden cities face due to clustering brought about by segregation. This study builds on previous research by directly measuring how spatially unequal health outcomes are within segregated cities. Utilizing Census-tract data from the Center for Disease Control and Prevention's 500 Cities project, we examine how different dimensions of spatial segregation are associated with the clustering of poor self-rated health in cities. We make novel usage of the Global Moran's I statistic to measure the spatial clustering of poor health within cities. We find spatial segregation is associated with poor health clustering, however the race/ethnicity and dimension of segregation matter. Our study contributes to existing research on segregation and health by unpacking the localized associations of residential segregation with poor health clustering in U.S. cities.

Entities:  

Keywords:  Moran’s I; poor health clustering; residential segregation; self-rated health

Year:  2020        PMID: 32492811     DOI: 10.3390/ijerph17113910

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  2 in total

1.  Residential segregation, neighborhood violence and disorder, and inequalities in anxiety among Jewish and Palestinian-Arab perinatal women in Israel.

Authors:  Nihaya Daoud; Samira Alfayumi-Zeadna; Aviad Tur-Sinai; Nabil Geraisy; Ilan Talmud
Journal:  Int J Equity Health       Date:  2020-12-09

2.  Participatory Approaches to Addressing Missing COVID-19 Race and Ethnicity Data.

Authors:  Farah Kader; Clyde Lanford Smith
Journal:  Int J Environ Res Public Health       Date:  2021-06-18       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.